Vaccine Ontology
1233 terms(s) returned
| Term Type: | Record: 1001 to 1050 of 1233 Records | Page: 21 of 25, First Previous Next Last | Show Records Per Page |
- head and neck cancer
- head and neck cancer vaccine
- head and neck carcinoma
- head and neck squamous cell carcinoma
- health-care and emergency medical services personnel
- heat-killed vaccine
- heat-killed virulent Shigella flexneri 2a
- hemA from Vibrio cholerae
- hemagglutination-inhibition assay
- hematologic cancer
- hematopoietic cell
- hematopoietic system disease
- hepatic merozoite stage
- hepatic schizont stage
- hepatic trophozoite stage
- hepatitis A
- hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US)
- hepatitis A vaccine (inactivated) strain HM175 / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Injectable Suspension [ViATIM]
- hepatitis A vaccine (inactivated) strain HM175 / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Prefilled Syringe
- hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.025 MG/ML Prefilled Syringe
- hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Injection
- hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Injection [Havrix]
- hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Prefilled Syringe
- hepatitis A vaccine (inactivated) strain HM175 1440 UNT/ML Prefilled Syringe [Havrix]
- hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML Injectable Suspension
- hepatitis A vaccine (inactivated) strain HM175 Injectable Suspension
- hepatitis A vaccine adult dosage
- hepatitis A vaccine pediatric dosage unspecified formulation
- hepatitis A vaccine pediatric/adolescent dosage 3 dose schedule
- hepatitis A vaccine unspecified formulation
- hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule
- hepatitis A virus / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Injectable Suspension
- hepatitis A virus / typhoid Vi polysaccharide vaccine, S typhi Ty2 strain Injectable Suspension [ViATIM]
- hepatitis A virus as vaccine component
- hepatitis A virus strain CR 326F antigen, inactivated
- hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML
- hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Injection
- hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Injection [Vaqta]
- hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Prefilled Syringe
- hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML Prefilled Syringe [Vaqta]
- hepatitis A virus strain CR 326F antigen, inactivated 50 UNT/ML [Vaqta]
- hepatitis A virus strain CR 326F antigen, inactivated Injection
- hepatitis A virus strain CR 326F antigen, inactivated Injection [Vaqta]
- hepatitis A virus strain CR 326F antigen, inactivated Prefilled Syringe
- hepatitis A virus strain CR 326F antigen, inactivated Prefilled Syringe [Vaqta]
- hepatitis A virus strain CR 326F antigen, inactivated vaccine
- hepatitis B
- hepatitis B immune globulin passive vaccine
- hepatitis B surface antigen (isoform L), recombinant 0.01 MG/ML
- hepatitis B surface antigen (isoform L), recombinant 0.01 MG/ML / hepatitis B surface antigen (isoform M), recombinant 0.01 MG/ML / hepatitis B surface antigen (isoform S), recombinant 0.01 MG/ML Injection
